SCA
GSK icon

SAC Capital Advisors’s GSK GSK Stock Holding History

SAC Capital Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4,737
Closed -$316K – 428
2014
Q1 		$316K Buy
+4,737
New +$320K ﹤0.01% 1385
2013
Q4 		– Sell
-7,170
Closed -$450K – 1852
2013
Q3 		$450K Sell
7,170
-3,073
-30% -$198K ﹤0.01% 1189
2013
Q2 		$640K Buy
+10,243
New +$650K ﹤0.01% 1024

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SAC Capital Advisors's GSK Position: Q2 2014 in Review

SAC Capital Advisors sold out of GSK (GSK) in Q2 2014, closing a stake of 4,737 shares — an estimated $316K sold.

SAC Capital Advisors first reported a position in GSK in Q2 2013 and held it in 3 quarters. The position peaked at $640K in Q2 2013. 722 funds tracked by Wall St. Rank hold GSK as of Q2 2014.

  • SAC Capital Advisors reported no remaining GSK position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 4,737 GSK shares in Q2 2014, an estimated $316K.
  • SAC Capital Advisors first reported a position in GSK in Q2 2013 and held it in 3 quarters.
  • SAC Capital Advisors's GSK position peaked at $640K in Q2 2013.
  • 722 funds tracked by Wall St. Rank held GSK as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.